The group's letter to the acting FDA commissioner says all favorable votes on BPC-157, TB-500 and others came from newly appointed members.
Recap by typeshit. Full story at Nutrition Insight.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
The once-weekly autoinjector is cleared for type 2 diabetes, overweight and obesity. Lilly never officially sold Mounjaro in Russia, and its rights there ended in November 2024.
In the 308-person REMAIN-1 study, Revita patients held onto about 80% of their lost weight versus 67% with sham. Fractyl plans an FDA filing in late 2026.
Loading…